Nanotechnology Now





Heifer International

Wikipedia Affiliate Button


DHgate

Home > Press > Synthetic Biology Taps DNA's Business Potential

Abstract:
"Synbio" sparking changes in energy, healthcare and agriculture according to Lux Research

Synthetic Biology Taps DNA's Business Potential

Boston, MA | Posted on February 26th, 2009

Promising everything from algae-derived petroleum to personalized medicine to drought-resistant crops, synthetic biology - or synbio - is rapidly sprouting disruptive new technologies in energy, healthcare, specialty chemicals, and agriculture. Despite the diverse and explosive nature of synbio's growth opportunities, however, there's been little or no meaningful commercial analysis of the field to date.

Until now… Following close review of dozens of companies, thousands of practitioners and over $1 billion in investments, Lux Research this week introduced the synbio sector's first-ever strategic market report. Entitled "Synthetic Biology's Commercial Roadmap," the report provides a definitive summation of potential opportunities enabled through the "discovery, invention, and manufacture of biochemical elements and systems to produce tools, materials, organisms, and devices that meet human needs."

Corporate decision-makers responsible for R&D, partnerships and business development will all find in Lux's roadmap a framework to help them separate hype from reality and identify synbio's real-world economic opportunities. The report offers intelligence on:

· The types of products enabled by synthetic biology, and where and when those products will become commercially competitive in select industries;

· Where the venture opportunities are today, where they will emerge tomorrow;

· What economic and scientific hurdles synbio technologies still need to negotiate.

"As a rule of thumb, we found that the higher up an application is on the scale of life, the more distant its commercialization launch," said Mark Bünger, a Research Director at Lux Research and the report's lead author. "Start-ups sequencing or synthesizing DNA to program microbes, for example, are already operating in established markets and with well-defined products like biofuels, drugs, and specialty chemicals. Meanwhile, engineered cells leading to devices like DNA circuits or biosensors remain at the proof of concept stage."

To map the outlines of the synbio sector, the authors visited leading labs, spoke with scientists and investors, and evaluated 72 companies' activities through a combination of executive interviews and secondary research. They examined 231 patents and 615 scientific papers that comprise the formal body of intellectual property, and spotted 41 private investments in the space to date. Among their key findings:

· Incumbent corporations are investing directly into startups - such as Chevron's funding of Solazyme - while top VCs like Khosla Ventures and Kleiner Perkins are putting hundreds of millions of dollars into fuel- and medicine-makers like Amyris, LS9 and Gevo.

· Noncorporate organizations like the iGEM competition are using the open-source software movement as a model, and playing a central role in advancing synthetic biology.

· Government funding is more coordinated in Europe, led by the EU's 6th Framework program (FP6) which provides millions of euros in funding for 18 synthetic biology research and policy initiatives and five economic development projects.

"Countless commercially valuable materials like penicillin and crude oil, and processes like carbon sequestration and bioremediation, all derive from plants' and animals' metabolic pathways, which are in turn determined by their genes," said Bünger. "Synthetic biology has opened new pathways for us to reprogram those metabolic pathways like software, and design products in countless industries with a revolutionary new degree of freedom."

"Synthetic Biology's Commercial Roadmap" is part of Lux Research's Bioscience Intelligence Service. Clients subscribing to this service receive continuous research on the biosciences industry, market trends and forecasts, ongoing technology scouting reports and proprietary data points in the weekly Lux Research Bioscience Journal and on-demand inquiry with Lux Research analysts.

####

About Lux Research, Inc.
Lux Research provides strategic advice and on-going intelligence for emerging technologies. Leaders in business, finance and government rely on us to help them make informed strategic decisions. Through our unique research approach focused on primary research and our extensive global network, we deliver insight, connections and competitive advantage to our clients.

For more information, please click here

Contacts:
Carole Jacques
Lux Research, Inc.
617-502-5314

Copyright © Lux Research, Inc.

If you have a comment, please Contact us.

Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.

Bookmark:
Delicious Digg Newsvine Google Yahoo Reddit Magnoliacom Furl Facebook

Related News Press

News and information

Conversion of Greenhouse Gases to Syngas in Presence of Nanocatalysts in Iran May 22nd, 2015

New Antibacterial Wound Dressing in Iran Can Display Replacement Time May 22nd, 2015

Haydale Named Lead Sponsor for Cambridge Graphene Festival May 22nd, 2015

Simulations predict flat liquid May 21st, 2015

Synthetic Biology

Researchers of the University of Tartu create a centre for developing designer cells with new functions April 8th, 2015

Democratizing synthetic biology: New method makes research cheaper, faster, and more accessible March 3rd, 2015

New tool could help reshape the limits of synthetic biology: The 'telomerator' reshapes synthetic yeast chromosome into more flexible, realistic form, redefining what geneticists can build November 3rd, 2014

Tiny carbon nanotube pores make big impact October 29th, 2014

Announcements

Conversion of Greenhouse Gases to Syngas in Presence of Nanocatalysts in Iran May 22nd, 2015

New Antibacterial Wound Dressing in Iran Can Display Replacement Time May 22nd, 2015

Haydale Named Lead Sponsor for Cambridge Graphene Festival May 22nd, 2015

INSIDDE: Uncovering the real history of art using a graphene scanner May 21st, 2015

Interviews/Book Reviews/Essays/Reports/Podcasts/Journals/White papers

Conversion of Greenhouse Gases to Syngas in Presence of Nanocatalysts in Iran May 22nd, 2015

Simulations predict flat liquid May 21st, 2015

Researchers develop new way to manufacture nanofibers May 21st, 2015

Nanotherapy effective in mice with multiple myeloma May 21st, 2015

Food/Agriculture/Supplements

Supercomputer unlocks secrets of plant cells to pave the way for more resilient crops: IBM partners with University of Melbourne and UQ May 21st, 2015

QuantumSphere Announces Production-Scale Validation of Nano Iron Catalysts for Multi-Billion Dollar Ammonia Industry: Significant Improvement in Ammonia Production for Agricultural Fertilizer, Global Food Crops May 7th, 2015

Nanoparticles in consumer products can significantly alter normal gut microbiome May 4th, 2015

Research seeks alternatives for reducing bacteria in fresh produce using nanoengineering April 29th, 2015

Energy

Conversion of Greenhouse Gases to Syngas in Presence of Nanocatalysts in Iran May 22nd, 2015

Sandia researchers first to measure thermoelectric behavior by 'Tinkertoy' materials May 20th, 2015

Industrial Nanotech, Inc. Announces Official Launch of the Eagle Platinum Tile™ May 19th, 2015

FEI and Weatherford Enter Into Joint Agreement for Advanced Reservoir Characterization Services May 18th, 2015

NanoNews-Digest
The latest news from around the world, FREE




  Premium Products
NanoNews-Custom
Only the news you want to read!
 Learn More
NanoTech-Transfer
University Technology Transfer & Patents
 Learn More
NanoStrategies
Full-service, expert consulting
 Learn More










ASP
Nanotechnology Now Featured Books




NNN

The Hunger Project